C3 and autoimmune disease: Given that complement C3 levels are significantly decreased in patients with different types of autoimmune diseases[21,22], and that inflammation secondary to an autoimmune response to the nucleus pulposus has been implicated as a primary pain source in DLBP[23], we speculate that dysregulation of the complement system has a key role in the pathogenesis of DLBP.